On Tuesday, BioLife Solutions, Inc. (NASDAQ:BLFS)’s shares surged 21.47% to $2.32, as BioLife declared preliminary first quarter financial results about a month ahead of its official earnings release date.
The company said that it generated preliminary proceed of $1.5 million which was comprised entirely of proprietary product proceed, a 30% raise over the same period last year. The propriety product proceed raise for the company was driven by a 92% year over year raise from customers in its regenerative medicine segment.
Analysts at Zacks reiterated their “buy” rating on the company following the declaration recently with a $6 price target.
BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. The company’s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death.
Builders FirstSource, Inc. (NASDAQ:BLDR)’s shares gained 17.46% to $13.59, during the last trading session on Tuesday, hitting its highest level, as Builders FirstSource will hold a conference call and webcast on Friday, April 24th, to talk about the company’s first quarter 2015 financial results and other business matters. The teleconference will start at 10:00 a.m. Central Time and will be hosted by Floyd Sherman, Chief Executive Officer, and Chad Crow, President, Chief Operating Officer and Chief Financial Officer.
Builders FirstSource, Inc. manufactures and supplies structural and related building products for residential new construction primarily in the southern and eastern United States. The company offers prefabricated components, counting floor trusses, roof trusses, wall panels, stairs, and engineered wood; and window and door products, such as aluminum and vinyl windows, and pre-hung interior and exterior doors, in addition to assembles and distributes interior and exterior door units.
At the end of Tuesday’s trade, Vaalco Energy Inc. (NYSE:EGY)’s shares surged 15.91% to $2.55, after VAALCO Energy declared first production from Etame 12-H, a development well drilled from the Etame platform offshore Gabon. Etame 12-H was drilled to a measured depth of about 3,450 meters targeting the recently discovered, untapped lower lobe of the Gamba reservoir. Following completion operations, the well was brought online at the rate of about 2,000 BOPD on a gross basis (about 500 BOPD net to VAALCO) with no indication of hydrogen sulfide (H2S). The well is presently being temporarily constrained at the above production level while it is being optimized for efficiency. The Etame 12-H is an offset well to the Etame 10-H well which began producing in February 2015, at a rate of 3,000 BOPD, and was the first oil production from the recently commissioned Etame platform.
The contracted jack up rig, the Transocean “Constellation II”, is now being mobilized to drill additional development wells from the Southeast Etame/N. Tchibala (“SEENT”) platform, starting with the 2-H well in the Southeast Etame field, where the Company and its partners drilled a successful exploration well in 2010. Following the drilling of the Southeast Etame 2-H well, the rig will drill the North Tchibala 1-H well, the first of VAALCO’s wells offshore Gabon to be drilled targeting the Dentale formation. No H2S is predictable from the Southeast Etame/N. Tchibala fields.
VAALCO Energy, Inc., an independent energy company, attains, explores for, develops, and produces crude oil and natural gas in the United States. The company owns producing properties and conducts exploration activities as an operator of consortiums internationally in Gabon and Angola, in addition to conducts exploration activities as a non-operator in Equatorial Guinea, West Africa.
Finally, Perseon Corporation (NASDAQ:PRSN), ended its Tuesday’s trading session with 14.68% gain, and closed at $0.40, after Perseon declared that the company has received clearance from the U.S. Food and Drug Administration (FDA) to market the MicroThermX(R) Microwave Ablation System (MicroThermX) for the specific indication of ablation procedures requiring partial or complete ablation of non-resectable liver tumors.
Perseon Corporation, a life sciences company, develops, manufactures, markets, and services medical systems to treat cancer and benign diseases using heat therapy. The company offers MicroThermX microwave ablation system that comprises a microwave generator, single-patient-use disposable antennas with cooling circuit, and a thermistor based temperature monitoring system; and employs precision-guided microwave energy to ablate diseased soft tissue.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
